High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission (Q44712849)

5 December 2017

title

High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission (English)

1 reference

5 December 2017

Nadal E

1

1 reference

5 December 2017

Giné E

2

1 reference

5 December 2017

Bladé J

3

1 reference

5 December 2017

Esteve J

4

1 reference

5 December 2017

Rosiñol L

5

1 reference

5 December 2017

Fernández-Avilés F

6

1 reference

5 December 2017

Marin P

7

1 reference

5 December 2017

Martinez C

8

1 reference

5 December 2017

Rovira M

9

1 reference

5 December 2017

Urbano-Ispizua A

10

1 reference

5 December 2017

Carreras E

11

1 reference

5 December 2017

Montserrat E

12

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Bone Marrow Transplantation

5 December 2017

published in

1 reference

5 December 2017

volume

33

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

61-64

1 reference

Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

VAD-based regimens as primary treatment for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

7 January 2021

Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

7 January 2021

High-dose therapy autotransplantation/intensification vs continued standard chemotherapy in multiple myeloma in first remission. Results of a non-randomized study from a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

7 January 2021

Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704313

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704313

1 reference

5 December 2017

1 reference